University of Naples Federico II at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University of Naples Federico II brings 8 presentations to ESGCT 2026 in Hamburg. Its work centres on AAV gene therapy for inherited retinal disease and for the nervous system, including compact cell-type-specific promoters designed with machine learning. Other strands cover a nanobody shuttle across the blood-brain barrier and substrate reduction for GM2 gangliosidoses.
| Organization | ESGCT 2026 Attendance |
|---|---|
University of Naples Federico II Naples, Italy | |
Poster Wed Oct 28 1:30pm–3:30pm A single zinc finger regulator enables multilayer transcriptional control for RHO-ADRP gene therapy Poster Wed Oct 28 1:30pm–3:30pm Impact of autophagy modulation on oncolytic adenovirus-based therapy Poster Wed Oct 28 1:30pm–3:30pm MicroRNAs enhance direct reprogramming of somatic cells into dopaminergic neurons Poster Wed Oct 28 1:30pm–3:30pm PROMetheus: AI-Driven De Novo Design of Compact, Cell-Type-Specific Promoters for AAV Gene Therapy Poster Wed Oct 28 1:30pm–3:30pm Substrate reduction gene therapy targeting (SRGT) B4GALNT1 for GM2 gangliosidoses. Poster Thu Oct 29 2:00pm–4:00pm AAV9-mediated allele-specific silencing of CACNA1C mutant allele in patient-derived iPSC-cardiomyocytes modelling Timothy syndrome (TS) Poster Thu Oct 29 2:00pm–4:00pm Anti-HBEGF nanobody as a novel blood-brain barrier transcytosis shuttle for brain drug delivery Poster Thu Oct 29 2:00pm–4:00pm Modeling core rod photoreceptor transcription In Vitro: A High-Throughput platform gene therapy screening for Retinitis Pigmentosa. |
Instantly find 20 buyers from University of Naples Federico II
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction